Antonio Vena

Best Publications

• How to manage Pseudomonas aeruginosa infections.

  Matteo Bassetti;Antonio Vena;Antony Croxatto;Elda Righi

  774
  Citations

• The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm.

  Matteo Bassetti;Antonio Vena;Daniele Roberto Giacobbe

  470
  Citations

• Treatment of Infections Due to MDR Gram-Negative Bacteria.

  Matteo Bassetti;Maddalena Peghin;Antonio Vena;Daniele Roberto Giacobbe

  339
  Citations

• Bloodstream infections in critically ill patients with COVID-19.

  Daniele Roberto Giacobbe;Denise Battaglini;Lorenzo Ball;Iole Brunetti

  294
  Citations

• A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality

  Matteo Bassetti;Elda Righi;Filippo Ansaldi;Maria Merelli

  256
  Citations

• Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project

  Matteo Bassetti;Matteo Bassetti;Daniele R Giacobbe;Antonio Vena;Cecilia Trucchi

  227
  Citations

• Distinct phenotypes require distinct respiratory management strategies in severe COVID-19.

  Chiara Robba;Denise Battaglini;Lorenzo Ball;Nicolo’ Patroniti

  180
  Citations

• Triple combination therapy with two antivirals and monoclonal antibodies for persistent or relapsed SARS-CoV-2 infection in immunocompromised patients.

  Unknown

  174
  Citations

• Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates.

  Jesús Guinea;Pilar Escribano;Antonio Vena;Patricia Muñoz

  166
  Citations

• Dalbavancin in the treatment of different gram-positive infections: a real-life experience

  Emilio Bouza;Maricela Valerio;Alex Soriano;Laura Morata

  166
  Citations

• Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors

  Unknown

  162
  Citations

• Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience.

  Matteo Bassetti;Nadia Castaldo;Annamaria Cattelan;Cristina Mussini

  156
  Citations

• Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug- resistant/extensively drug-resistant/pandrug-resistant bacteria

  Matteo Bassetti;Elda Righi;Antonio Vena;Elena Graziano

  144
  Citations

• Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM.

  Unknown

  143
  Citations

• Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study.

  Unknown

  142
  Citations

• Inhaled Liposomal Antimicrobial Delivery in Lung Infections

  Matteo Bassetti;Antonio Vena;Alessandro Russo;Maddalena Peghin

  133
  Citations

• Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study.

  Daniele Roberto Giacobbe;Denise Battaglini;Elisa Martina Enrile;Chiara Dentone

  131
  Citations

• Spread of Carbapenem-Resistant Gram-Negatives and Candida auris during the COVID-19 Pandemic in Critically Ill Patients: One Step Back in Antimicrobial Stewardship?

  Laura Magnasco;Malgorzata Mikulska;Daniele Roberto Giacobbe;Lucia Taramasso

  122
  Citations

• Tocilizumab and steroid treatment in patients with COVID-19 pneumonia.

  Malgorzata Mikulska;Laura Ambra Nicolini;Alessio Signori;Antonio Di Biagio

  119
  Citations

• Antifungal stewardship in daily practice and health economic implications

  Patricia Muñoz;Patricia Muñoz;Maricela Valerio;Antonio Vena;Antonio Vena;Emilio Bouza;Emilio Bouza

  116
  Citations